P251 (Hyoscyamine sulfate extended release 0.375 mg)

Pill imprint P251 has been identified as Hyoscyamine sulfate extended release 0.375 mg.

Hyoscyamine is used in the treatment of irritable bowel syndrome; anesthesia; crohn's disease; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine 0.375 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for P251

Hyoscyamine sulfate extended release 0.375 mg P251
Hyoscyamine sulfate extended release
Imprint:
P251
Strength:
0.375 mg
Color:
White
Size:
13.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergics/antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0251
Inactive Ingredients:
lactose anhydrous
hypromellose 2208 (15000 mPa.s)
silicon dioxide
magnesium stearate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)